National AIDS Center, Istituto Superiore di Sanita, Rome, Italy Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2004
NCT00529698
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

National AIDS Center (CNAIDS), Istituto Superiore di Sanita', Rome, Italy

Active Ingredients

Drugs in Phase 2 Trials (1)

recombinant hiv-1 tat protein (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1